Home › Funds › AustralianSuper Pty Ltd › GILD

AustralianSuper Pty Ltd position in GILD

GILEAD SCIENCES INC · Health Care

AustralianSuper Pty Ltd reported holding 1,224,724 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$182.5M, representing 0.75% of its reported portfolio and ranking #30 among its reported holdings. AustralianSuper Pty Ltd has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.22M sh
Reported value held$182.55M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AustralianSuper Pty Ltd's GILD position evolved

AustralianSuper Pty Ltd first disclosed a stake in GILD in Q3 2023 at 199,796 shares (US$15.0M). The position peaked in Q2 2025 at 3,378,055 shares, worth US$374.5M. Across 13 filings, AustralianSuper Pty Ltd increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,224,724 shares valued at US$182.5M — a reduction of -46,733 shares quarter over quarter.. Notable position changes include a 76% increase in Q1 2024 (shares fell 6% over the following quarter), a 150% increase in Q2 2024 (shares rose 22% over the following quarter), a 169% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 199.80K $14.97M New
Q4 2023 231.54K $18.76M Add
Q1 2024 406.67K $29.64M Add
Q2 2024 1.02M $69.75M Add
Q3 2024 1.13M $94.93M Add
Q4 2024 1.14M $105.14M Add
Q1 2025 3.06M $342.62M Add
Q2 2025 3.38M $374.52M Add
Q3 2025 3.03M $336.78M Reduce
Q4 2025 2.57M $315.10M Reduce
Q1 2026 1.44M $200.16M Reduce
Q2 2026 1.27M $160.64M Reduce
Q3 2026 1.22M $182.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has AustralianSuper Pty Ltd held GILD?

AustralianSuper Pty Ltd has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AustralianSuper Pty Ltd's current position in GILD?

As of Q3 2026, AustralianSuper Pty Ltd holds 1.22M shares of GILD (GILEAD SCIENCES INC), valued at $182.55M, representing 0.75% of its reported portfolio and ranking #30.

Has AustralianSuper Pty Ltd been buying or selling GILD?

In the latest 13F filing (Q3 2026), AustralianSuper Pty Ltd reduced its position in GILD. The position peaked in Q2 2025 at 3.38M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.